Boston Scientific's 16% Sales Growth Fails to Impress as Soft Outlook Spooks Investors

Boston Scientific · Earnings · Guidance · Sales

Read More On

Boston Scientific Profit, Sales Rise but Issues Soft Guidancewsj.comBoston Scientific Sees More Growth after Earnings, Sales Rise - marketscreener.commarketscreener.com

Related Articles

Markets★★Similarity: 69% · 74d ago

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

The pharma major said it faces the largest drug-patent expiry headwind in its history this year.

Markets★★Similarity: 69% · 76d ago

Teradyne Profit Rises as Sales Surge on AI-Related Demand

The company, which makes testing equipment for semiconductors and robotics, posted a fourth-quarter profit of $257.2 million, up from $146.3 million a year earlier.

Tech★★Similarity: 68% · 68d ago

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

Markets★★Similarity: 68% · 74d ago

GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic environment.